ascopubs.org

VEGF-A 165 family of isoforms as predictive biomarkers in patients with nonsquamous non-small cell lung cancer (NSCLC) treated with bevacizumab.

Treatment of advanced recurrent NSCLC with daily oral vinorelbine: A phase I trial. This is an ASCO Meeting Abstract from the 2013 ASCO Annual Meeting I. This abstract does not include a full text ...
BIOENGINEER

Splice Variant VEGF165b Emerges as a Natural Shield Against Acute Lung Injury

A newly published study identifies the VEGF-A splice variant VEGF165b as an endogenous protector that shields the lung's ...
ascopubs.org

VEGF suppression via exon 2 splice-switching Vivo-Morpholino antisense oligo to inhibit tumor growth in a mouse subcutaneous model.

Targeted delivery of topotecan via folic acid functionalized phycocyanin nanoparticles for ovarian cancer. This is an ASCO Meeting Abstract from the 2026 ASCO Breakthrough. This abstract does not ...